Carl Zeiss Meditec AG (ETR:AFX – Get Free Report) shares hit a new 52-week low on Monday . The company traded as low as €61.25 ($66.58) and last traded at €62.25 ($67.66), with a volume of 89963 shares changing hands. The stock had previously closed at €62.25 ($67.66).
Carl Zeiss Meditec Stock Performance
The stock has a market cap of $5.57 billion, a P/E ratio of 21.25, a price-to-earnings-growth ratio of 3.45 and a beta of 0.93. The stock’s 50 day simple moving average is €77.97 and its two-hundred day simple moving average is €96.69. The company has a debt-to-equity ratio of 6.74, a current ratio of 3.51 and a quick ratio of 2.47.
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Featured Stories
- Five stocks we like better than Carl Zeiss Meditec
- High Flyers: 3 Natural Gas Stocks for March 2022
- Intuitive Surgical Stock Outperforms Market: Highs on the Horizon
- Investing in Travel Stocks Benefits
- Has This Leading Tech Stock Halted the AI Surge?
- Quiet Period Expirations Explained
- Revolutionary Battery Stock Gains Momentum with 3D Silicon-Anodes
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
